METHOD FOR DIFFERENTIATING MESENCHYMAL STEM CELL INTO NEURAL CELL AND PHARMACEUTICAL COMPOSITION CONTAINING THE NEURAL CELL FOR NEURODEGENERATIVE DISEASE
Patent №
US 7,635,591
Granted
2009-12-22
Filed 2006
Owner
FCB PHARMICELL CO., LTD.
+3 more
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
10595620
The present invention provides a method of differentiating and proliferating a mesenchymal stem cell into the neural cell by culturing in a medium comprising an epidermal growth factor and a hepatocyte growth factor after confluent culture of the mesenchymal stem cell. The present invention provides more effective method of differentiating and proliferating the mesenchymal stem cell or the mononuclear cell comprising the mesenchymal stem cell into the neural cell with a neuron and an astrocyte in terms of time, efficiency and maturity as compared with conventional methods.
AI classification
Ownership
FCB PHARMICELL CO., LTD.
assignment · 175590733
HYUN-SOO KIM
assignment · 175590733
PHARMICELL CO., LTD.
namechg · 276210702
KIM, HYUN-SOO
namechg · 276210702
Assignors
KIM, HYUN-SOO, KANG, YOUNG-MO, LEE, KYUNG-BOCK, PARK, SANG-KYO, LEE, SANG-KAP
On an employer assignment, the assignors are typically the inventors.